Compare SBLK & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBLK | AORT |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | SBLK | AORT |
|---|---|---|
| Price | $19.52 | $46.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $22.00 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 1.4M | 358.0K |
| Earning Date | 02-17-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $1,050,829,000.00 | $422,646,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $19.54 | $10.96 |
| P/E Ratio | $37.00 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $12.06 | $21.97 |
| 52 Week High | $20.87 | $48.25 |
| Indicator | SBLK | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 52.24 |
| Support Level | $18.01 | $45.75 |
| Resistance Level | $18.40 | $48.00 |
| Average True Range (ATR) | 0.44 | 1.39 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 74.35 | 61.67 |
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.